YANG DIISI ADALAH KOLOM YANG BERWARNA MERAH MUDA

PENGISIAN ANGKA VALUE DALAM PER SEJUTA ( / 1.000.000)

TGRMAXS03 CHAIRUDDIN

CHANNEL
BRANCH DESC SUP ASM NAME GROUP FPP CUSTOMER DESC POTENSI /
(REG RSU RSS) BULAN (HNA)

TGR SAHRU RAMADHAN REG AP MANJUR SEHAT 86

TGR SAHRU RAMADHAN REG APT FORTUNA 93
TGR SAHRU RAMADHAN REG APT PROLIFE 50
TGR SAHRU RAMADHAN REG APT GOR MEDIKA 50
TGR SAHRU RAMADHAN REG OTHERS 100
TGR SAHRU RAMADHAN TOTAL REG 379
TGR SAHRU RAMADHAN RSS RS OMNI ALAM SUTERA 1,760
TGR SAHRU RAMADHAN RSS RS SARI ASIH CIPUTAT 809
TGR SAHRU RAMADHAN RSS RS CAROLUS 991
TGR SAHRU RAMADHAN RSS RS EMC 850
TGR SAHRU RAMADHAN RSS
TGR SAHRU RAMADHAN TOTAL RSS 4,410
TGR SAHRU RAMADHAN RSU RS BHAYANGKARA
TGR SAHRU RAMADHAN RSU RSU KOTA TANGERANG
TGR SAHRU RAMADHAN TOTAL RSU -
TOTAL TOTAL TOTAL 4,789

NOTE :
1, SLS DLM JUTAAN
2.POTENSI SALES DIDAPAT DARI DATA SURVEY UTK ALL KOMPETITOR PRDUK FPP & PRO
3. SEMUA POPULASI SPESIALIS ( CARDIO, NEURO,INTERNIST)--->WAJIB MASUK MCL
4. TDK MERUBAH KOLOM & URUTAN SPESIALIS

NOTE
1 ACTION PLAN HARUS MENCERMINKAN MIN.80% DARI BE Q1 2020
2 POINT (1) DITUANGKAN DALAM TOTAL RSS DAN REG

1 Estimasi Q1 vs Avg 2019 (JAN - OKT) GWT min.17% (by Total PIMDA)
 BEST EST Q1 ACT Q1

AVERAGE SALES
VALUE 1 2 3 1 2 3
(AVG JAN – OKT
2021)

3 6 6 8 2 2 2
0 3 3 3 1 27
- 2 3 4 - -
3
10 10 10 10 11 10 12
16 21 22 25 13 13 41
73 100 102 105 78 47 105
96 110 111 113 195 257 194
9 13 15 18 13 6 8
2 21 23 24 6 3 6

180 244 251 260 291 313 313

1

- - - - 1
195 265 273 285 305 326 354

UTK ALL KOMPETITOR PRDUK FPP & PRODUK FPP

O,INTERNIST)--->WAJIB MASUK MCL
 BEST EST Q2

SHARE AVG
4 5 6 FERRON AVG FERRON AVG 2022 VS 2021 Q2 thdp
Q1 2022 Q2 2022 POTENSI

6 7 7 2 7 -34.48% 8%
10 16 18 9 15 3011.11% 16%
1 3 3 - 2 #DIV/0! 5%
2 4 5 - 4 7%
12 12 12 11 12 11.00% 12%
31 42 45 22 39 42.25% 10%
109 125 139 77 124 5.17% 7%
212 220 227 215 220 124.31% 27%
16 25 29 9 23 0.00% 2%
10 16 17 5 14 143.33% 2%
- - #DIV/0!
347 386 412 306 382 70.10% 9%
1 1 1 0 1 #DIV/0! #DIV/0!
5 5 - 3 #DIV/0! #DIV/0!
1 6 6 0 4 #DIV/0! #DIV/0!
379 434 463 328 425 67.96% 9%
RSS DAN REG YANG DI PRESENTASIKAN HARUS MENJAWAB 80 % DARI SALES ESTIMASI RSS DAN REG Q1 2022 PADA SHEET SUMMARY
PENGISIAN ANGKA VALUE DALAM PER SEJUTA ( / 1.000.000)

No CHANEL LINK NAMA RSS & REG POTENSI / CHANEL NAMA RSS &
BULAN (HNA) REG

1REG REG AP MANJUR SE

1REG REG AP MANJUR SE
1REG REG AP MANJUR SE
1REG REG AP MANJUR SE
1 REG AP MANJUR SEHAT 86
1REG REG AP MANJUR SE
1REG REG AP MANJUR SE
1REG REG AP MANJUR SE
1REG REG AP MANJUR SE
2REG REG APT FORTUNA
2REG REG APT FORTUNA
2REG REG APT FORTUNA
2REG REG APT FORTUNA
2 REG APT FORTUNA 75
2REG REG APT FORTUNA
2REG REG APT FORTUNA
2REG REG APT FORTUNA
2REG REG APT FORTUNA
3REG REG APT PROLIFE
3REG REG APT PROLIFE
3REG REG APT PROLIFE
3REG REG APT PROLIFE
3 REG APT PROLIFE 50
3REG REG APT PROLIFE
3REG REG APT PROLIFE
3REG REG APT PROLIFE
3REG REG APT PROLIFE
REG TOTAL REG (SHEET SUMMARY) 311
1RSS RSS RS OMNI ALAM
1RSS RSS RS OMNI ALAM
1RSS RSS RS OMNI ALAM
1RSS RSS RS OMNI ALAM
1 RSS RS OMNI ALAM SUTERA 1,739
1RSS RSS RS OMNI ALAM
1RSS RSS RS OMNI ALAM
1RSS RSS RS OMNI ALAM
1RSS RSS RS OMNI ALAM
2RSS RSS RS SARI ASIH C
2RSS RSS RS SARI ASIH C

2 RSS RS SARI ASIH CIPUTAT 878

 2RSS RSS RS SARI ASIH C
2RSS RSS RS SARI ASIH C
2 RSS RS SARI ASIH CIPUTAT 878
2RSS RSS RS SARI ASIH C
2RSS RSS RS SARI ASIH C
2RSS RSS RS SARI ASIH C
2RSS RSS RS SARI ASIH C
3RSS RSS RS CAROLUS
3RSS RSS RS CAROLUS
3RSS RSS RS CAROLUS
3RSS RSS RS CAROLUS
3 RSS RS CAROLUS 991
3RSS RSS RS CAROLUS
3RSS RSS RS CAROLUS
3RSS RSS RS CAROLUS
3RSS RSS RS CAROLUS
RSS TOTAL RSS (SHEET SUMMARY) 4,458
EG Q1 2022 PADA SHEET SUMMARY

FERRON dan Kompetitor

AVERAGE KONTRIBUSI
PT SALES VALUE FERRON AVG vs TOTAL
(AVG JAN – Q1 2022 PLAN
OKT 2021)

FERRON 3
KALBE 20
SANBE 15
DEXA 20 8 9.3%
………….. -
………….. -
OTHERS 28
SUB TOTAL REG 86
FERRON 0
MAHAKAM 30
SAMBE 15
DEXA 25 3 4.0%
………….. -
………….. -
OTHERS 5
SUB TOTAL REG 75
FERRON -
KALBE 20
SANBE 10
LAPI 15 4 8.0%
………….. -
………….. -
OTHERS 5
SUB TOTAL REG 50
TOTAL REG FE 3 15 60.0%
FERRON 73
INTERBAT 700
SANBE 750
DEXA 350 105 6.0%
………….. -
………….. -
OTHERS -134
SUB TOTAL RSS 1,739
FERRON 96
KALBE 350

113 12.9%
SANBE 350
DEXA 200 113 12.9%
………….. -
………….. -
OTHERS -118
SUB TOTAL RSS 878
FERRON 9
KALBE 300
SANBE 250
INTERBAT 100 18 1.8%
………….. -
………….. -
OTHERS 332
SUB TOTAL RSS 991
TOTAL RSS FER 178 236 90.8%
 CHANEL REG
No: 1
Nama Apotik: AP MANJUR SEHAT

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP? Product
No
Nama Specialis NORMAL PANDEMI Y/N Existing (FPP)
GLUMIN XR

1 WARDHANA Sp.PD 46 Y

SUB TOTAL

TELSAT

2 EMILE TUMPAL Sp.JP 40 Y

SUB TOTAL
Grand Total 86 TOTAL
Pengguna Feron 2 TOTAL AP MANJUR SEHAT
Bukan Pengguna Ferron -
 AVERAGE Produk Kompetitor
SALES 2021 -Gusur- EST Q1
(AVG JAN - Produk AQ/AO
PT. Nama Produk Sales (Rp) 1 2
OKT 2021)
1 MERCK GLUCOPAGE XR 5 GLUMIN XR 1 1
- DEXA STATOR 5 - -
SERVIER DIAMICRON MR 4 FONYLIN MR 1 1
SANBE TEXAGRAM 5 - -
INTERBAT INVOMIT 3 - -
LAPI IMUNOS 3 BIOBRAN 1 1
ASTRA NEXIUM 3 ESOFERR CAP - -
OTHERS 10 - -
- -
1 - - 38 - 3 3
- SANOFI TRITACE 6 - -
- DEXA STATOR 10 ROSUFER 1 1
1 BOEHRINGER MICARDIS 5 TELSAT 1 1
MSD EZETROL 5 EZEFER 1 1
EISAI ARICEFT 3 - -
- -
OTHERS 10 - -
- -
- -
1 - - 39 - 3 3
1 77 6 6
TAL AP MANJUR SEHAT
EST Q1 ACT Q1 EST Q2
3 1 2 3 4 5 6
1 1 1 1 1 1 1
-
2 1 1 1 1 1
-
-
1
1 1 1
-
-
5 2 1 1 2 3 3
-
1
1 0 3 3 3
1 1 1 1 1
-
-
-
-
-
3 - 1 - 4 4 4
8 2 2 1 6 7 7
FERRON AVG FERRON AVG ACTION PLAN DEADLINE PIC (NAMA
Q1 2022 Q2 2022 MONTH MR/ PIMDA)
1 1
0 0
1 1
0 0
0 0 SIMPOSIUM KOPAPDI SEMARANG JUL WILDAN
1 0
0 1
0 0
0 0
4 3
0 0
0 0
0 3
0 1
0 0 PP ONLINE EZEFER MEI WILDAN
0 0
0 0
0 0
0 0
3 2
2 7
8
KETERANGAN
 CHANEL REG
No: 1
Nama Apotik: APT FORTUNA

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP? Product
No
Nama Specialis NORMAL PANDEMI Y/N Existing (FPP)

1 ONG SIAW LIN GP 93 N

SUB TOTAL
Grand Total 93 TOTAL
Pengguna Feron - TOTAL APT FORTUNA
Bukan Pengguna Ferron 1
 AVERAGE Produk Kompetitor
SALES 2021 -Gusur- EST Q1
(AVG JAN - Produk AQ/AO
PT. Nama Produk Sales (Rp) 1 2
OKT 2021)
DEXA STATOR 20 ROSUFER 1 1
- MSD EZETROL 5 EZEFER 1 1
MERCK GLUCOPAGE XR 5 GLUMIN XR
KALBE BRAINACT 5 NEULIN PS 1 1
LAPI LAMESON 10 MEDIXON - -
ASTRA NEXIUM 3 ESOFERR CAP - -
OTHERS 45 - -
- -
- -
- - - 93 - 3 3
- 93 3 3
TAL APT FORTUNA
EST Q1 ACT Q1 EST Q2
3 1 2 3 4 5 6
1 17 5 8 10
1 1 1
3 2 2 2
1 1 1 1
- 5 3 3 3
- 1 1
-
-
-
3 - 1 25 10 16 18
3 - 1 25 10 16 18
FERRON AVG FERRON AVG ACTION PLAN DEADLINE PIC (NAMA KETERANGAN
Q1 2022 Q2 2022 MONTH MR/ PIMDA)
6 8
0 1
1 2
0 1
2 SUER
3 DAN PMS 15 JT MEI WILDAN
0 1
0 0
0 0
0 0
9 15
9 15
3
 CHANEL REG
No: 1
Nama Apotik: APT PROLIFE

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP? Product
No
Nama Specialis NORMAL PANDEMI Y/N Existing (FPP)

1 NELLA SUHUYANSp.PD 50 N

SUB TOTAL
Grand Total 50 TOTAL
Pengguna Feron - TOTAL APT PROLIFE
Bukan Pengguna Ferron 1
 AVERAGE Produk Kompetitor
SALES 201 -Gusur- EST Q1
(AVG JAN - Produk AQ/AO
PT. Nama Produk Sales (Rp) 1 2
OKT 2021)
DEXA STATOR 10 ROSUFER 1 2
- MSD EZETROL 5 - -
LAPI LAMESON 10 - -
KALBE BRAINACT 5 - -
EISAI ARICEPT 2 FEPEZIL 1 1
ASTRA NEXIUM 3 ESOFERR CAP - -
- -
- -
- -
- - - 35 - 2 3
- 35 2 3
TAL APT PROLIFE
EST Q1 ACT Q1 EST Q2
3 1 2 3 4 5 6
2 1 1 1
- - - -
- - - -
- - - -
1 - 1 1
1 - 1 1
-
-
-
4 - - - 1 3 3
4 - - - 1 3 3
FERRON AVG FERRON AVG ACTION PLAN DEADLINE PIC (NAMA KETERANGAN
Q1 2022 Q2 2022 MONTH MR/ PIMDA)
0 1
0 0
0 0
ENT BUAH DR
0 0 NELA,
0 1 MENAWARKAN APRL WILDAN
KOPAPDI
0 1 SEMARANG BULAN
JULI
0 0
0 0
0 0
0 2
0 2
4
 CHANEL REG
No: 1
Nama Apotik: : APT GOR MEDIKA

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP? Product
No
Nama Specialis NORMAL PANDEMI Y/N Existing (FPP)
ROSUFER

1 MUTHALIP ABD Sp.PD Y

SUB TOTAL
ROSUFER

2 DIPDO SANTOS Sp.PD Y

SUB TOTAL
Grand Total - TOTAL
Pengguna Feron 2 TOTAL : APT GOR MEDIKA
Bukan Pengguna Ferron -
 AVERAGE Produk Kompetitor
SALES 2021 -Gusur- EST Q1
(AVG JAN - Produk AQ/AO
PT. Nama Produk Sales (Rp) 1 2
OKT 2021)
2 ASTRA CRESTOR 3 ROSUFER 2 2
- SANOFI RECANSA 2 - -
NOVELL NISTROL 2 - -
MSD EZETROL 1 EZEFERR 1 1
MSD DIAMICRON
MERCK GLUCOPHAGE
- -
- -
- -
2 - - 8 - 3 3
2 ASTRA CRESTOR 3 ROSUFER 1 1
- SANOFI RECANSA 2 - -
NOVELL NISTROL 2 - -
MSD EZETROL 1 EZEFERR 1 1
MSD DIAMICRON
ASTRA NEXIUM 3 ESOFERR CAP
- -
- -
- -
2 - - 11 - 2 2
5 19 5 5
TAL : APT GOR MEDIKA
EST Q1 ACT Q1 EST Q2
3 1 2 3 4 5 6
2 1 1 1
-
-
1 1 1 1

-
-
-
3 - - - 2 2 2
1 1 1
-
-
1 1

1 1
-
-
-
2 - - - - 2 3
5 - - - 2 4 5
FERRON AVG FERRON AVG ACTION PLAN DEADLINE PIC (NAMA
Q1 2022 Q2 2022 MONTH MR/ PIMDA)
0 1
0 0
0 0
0 1
0 0 ENT KOPI JANJI JIWA APRL WILDAN
0 0
0 0
0 0
0 0
- 2
0 1
0 0
0 0
0 0
0 0 ENT STARBUCK MEI WILDAN
0 1
0 0
0 0
0 0
- 2
0 2
#N/A
KETERANGAN
 CHANEL RSS
No: 1
Nama Apotik: RS OMNI ALAM SUTERA

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP?
No
Nama Specialis NORMAL PANDEMI Y/N

1 TJHANG SOEPARJO Sp.B 156 Y

2 NELLA SUHUYANLY Sp.PD 130 N

3 SULISTYOWATI OHNIO Sp.PD 121 Y

4 ALBERTUS EKA GANDAKUSUMA Lainnya 111 Y

4 ALBERTUS EKA GANDAKUSUMA Lainnya 111 Y

5 DANIEL THOMAS SURYADISASTRA Sp.S 88 Y

6 MOCH NAGIEB Lainnya 80 Y

7 SANDY PERKASA Sp.PD 73 N

8 ALFRED SUTRISNO SIMN Lainnya 73 Y

8 ALFRED SUTRISNO SIMN Lainnya 73 Y

9 EMILE TUMPAL HOMBARON Sp.JP 38 Y

10 BERLIAN INDRIANSYAH IDRIS Sp.JP 33 Y

11 PATRICIA SIMANDJAJA Sp.S 39 Y

12 MARTUA RIZAL SITUMORANG Sp.S 26 N

13 FEBRI KURNIAWATI Sp.PD 31 Y

14 WERDHANA Sp.PD 33 Y

15 FERDI LIMAWAL Sp.A 37 Y

16 DENNY SIMANJUNTAK GP 29 Y

17 DINTO PURWANDANU GP 21 N
17 DINTO PURWANDANU GP 21 N

18 R. RYAN ARDRIAN Sp.PD 26 N

19 IDRIS IDAM Sp.JP 29 N

20 JONATHAN HARTANTO GP 21 N

20 ANDRI Lainnya 21 N
 20 ANDRI Lainnya 21 N

21 OTHERS Lainnya 700 N

Grand Total 1,760

Pengguna Feron 13
 AVERAGE Produk Kompetitor
Product SALES 2021 -Gusur- BE Q1 2022
(AVG JAN – Produk AQ/AO
Existing (FPP) PT. Nama Produk Sales (Rp) 1
OKT 2021)
ESOFERR 42 OTTO ESOMAX 45 ESOFERR 42
- MSD ARCOXIA 10 COXIRON 1
DEXA REMOPAIN 15 -
SANBE PUMPITOR 20 -
SANBE TAXEGRAM 20 -
ROYAL VIPALBUMIN 4 POSAFIT 2
ASTRA NEXIUM 5 ESOFERR CAP -
-
-
SUB TOTAL 42 - - 119 - 45
- DEXA STATOR 10 -
- OTTO ESOMAX 20 ESOFERR 1
ASTRAZENECA CRESTOR 10 ROSUFER 1
SANBE PUMPITOR 25 -
ASTRA NEXIUM 3 ESOFERR CAP -
INTERBAT INVOMIT 15 -
INTERBAT INTIDROL 10 -
-
OTHERS 30 -
SUB TOTAL - - - 123 - 2
FONYLIN MR 1 SERVIER DIAMICRON MR 10 FONYLIN MR 1
- PFIZER LYRICA 5 -
MSD ARCOXIA 10 -
PFIZER CELEBREX 7 -
SANBE PUMPITOR 30 -
SANBE TEXAGRAM 30 -
INTERBAT INVOMIT 20 -
DEXA STATOR 8 ROSUFER 1
-
SUB TOTAL 1 - - 120 - 2
COXIRON 6 MSD ARCOXIA 15 COXIRON 6
- PFIZER CELEBREX 10 -
DEXA REMOPAIN 10 -
INTERBAT MELOXIN 15 -
INTERBAT OSSOVIT 15 -
 INTERBAT STARXON 25 -
DEXA REMOPAIN 15 -
-
-
SUB TOTAL 6 - - 105 - 6
COXIRON 1 MSD ARCOXIA 14 COXIRON 1
NEULIN PS 2 PHAROS ZEUFOR 10 NEULIN PS 2
NEULIN 1 PHAROS ZEUFOR 10 NEULIN 1
PGB 2 PFIZER LYRICA 10 PGB 2
JANSEN SIBELIUM 7 DEGRIUM 1
PHAROS TEBOKAN 6 -
SANBE PUMPITOR 20 -
EISAI ARICEPT 5 -
-
SUB TOTAL 6 - - 82 - 7
KETESE 3 DEXA REMOPAIN 10 KETESE 3
COXIRON 1 MSD ARCOXIA 10 COXIRON 1
PFIZER CELEBREX 5 -
INTERBAT MELOXIN 5 -
INTERBAT STARXON 5 -
BAYER AVELOX 5 -
-
-
OTHERS 40 -
SUB TOTAL 4 - - 80 - 4
- DEXA STATOR 5 ROSUFER 1
- OTTO ESOMAX 15 ESOFERR 1
DEXA REMOPAIN 10 -
SANBE PUMPITOR 20 -
ASTRA NEXIUM 3 ESOFERR CAP -
INTERBAT INVOMIT 10 -
INTERBAT INTIDROL 5 -
SERVIER DIAMICRON MR 3 -
-
SUB TOTAL - - - 71 - 2
COXIRON 1 MSD ARCOXIA 5 COXIRON 1
- SANBE PUMPITOR 10 -
SANBE TEXAGRAM 10 -
NEULIN PS 1 PHAROS TEBOKAN 5 NEULIN PS 1
NEULIN 1 PHAROS TEBOKAN 5 NEULIN 1
POSAFIT 1 ROYAL VIPALBUMIN 4 POSAFIT 1
ROYAL VIPALBUMIN 4 -
 ASTRA NEXIUM 3 ESOFERR CAP -
OTHERS 25 -
SUB TOTAL 4 - - 71 - 4
NTG 1 DARYA VARIA CEDOCARD 7 NTG 1
- SANOFI TRITACE 6 -
ROSUFER 1 DEXA STATOR 10 ROSUFER 1
BOEHRINGER MICARDIS 5 -
MSD EZETROL 5 EZEFER 1
EISAI ARICEFT 3 -
-
-
-
SUB TOTAL 2 - 36 3
NTG 1 DARYA VARIA CEDOCARD 7 NTG 1
- SANOFI TRITACE 6 -
DEXA STATOR 6 ROSUFER 1
BOEHRINGER MICARDIS 5 -
ASTRAZENECA CRESTOR 5 -
MSD EZETROL 3 EZEFER 1
-
-
-
SUB TOTAL 1 - 32 3
NEULIN PS 2 PHAROS ZEUFOR 4 NEULIN PS 1
NEULIN 1 PHAROS ZEUFOR 4 NEULIN 1
PGB 2 PFIZER LYRICA 5 PGB 2
PHAPROS TEBOKAN 6 -
INTERBAT INCELIN 6 -
EISAI ARICEPT 5 -
JANSEN SIBELIUM 4 DEGRIUM 1
-
-
SUB TOTAL 5 - 34 5
- DEXA STATOR 5 -
NEULIN - PHAROS ZEUFOR 5 NEULIN 1
NEULIN PS PHAROS ZEUFOR 6 NEULIN PS -
PFIZER LYRICA 6 -
JANSEN SIBELIUM 4 -
-
-
-
-
SUB TOTAL - - 26 1
FONYLIN MR 1 SERVIER DIAMICRON MR 6 FONYLIN MR 1
- OTTO ESOMAX 10 ESOFERR 1
ASTRAZENECA CRESTOR 5 ESOFER CAP -
SANBE PUMPITOR 5 -
BAYER AVELOX 5 MOLCIN 1
ASTRA NEXIUM 6 ESOFERR CAP -
-
-
-
SUB TOTAL 1 - 37 3
GLUMIN XR 0 MERCK GLUCOPAGE XR 5 GLUMIN XR 1
- DEXA STATOR 5 -
OTTO ESOMAX 5 -
FONYLIN MR SERVIER DIAMICRON MR 4 FONYLIN MR 1
SANBE TEXAGRAM 5 -
INTERBAT INVOMIT 3 -
INTERBAT INTIDROL 3 -
BAYER AVELOX 3 MOLCIN 1
ASTRA NEXIUM 3 ESOFERR CAP -
SUB TOTAL 0 - 36 3
KETRICIN 2 INTERBAT TRIAMCORT 5 KETRICIN 2
- INTERBAT INTRIZINE 5 -
INTERBAT ERDOBAT 9 -
SANBE CERINI 5 -
SANBE CEFAT 5 -
SANBE TEXAGRAM 5 -
-
-
-
SUB TOTAL 2 - 34 2
ESOFERR 1 SANBE PUMPITOR 5 ESOFERR 2
- SANBE PUMPISEL 5 -
ASTRAZENECA NEXIUM 10 -
DEXA REMOPAIN 6 KETESE 2
-
-
-
-
-
SUB TOTAL 1 - 26 4
- SANBE STATOR 5 ESOFERR 1
 - SANBE PUMPISEL 5 KETESE 1
ASTRAZENECA NEXIUM 5 -
DEXA STATOR 6 -
-
-
-
-
-
SUB TOTAL - - 21 2
- SANBE PUMPITOR 10 -
- SANBE PUMPISEL 5 -
SERVIER DIAMICRON MR 4 FONYLIN MR 1
DEXA REMOPAIN 6 -
ASTRA NEXIUM 5 ESOFERR CAP -
-
-
-
-
SUB TOTAL - - 30 1
- DARYA VARIA CEDOCARD 7 -
- SANOFI TRITACE 5 -
DEXA STATOR 5 ROSUFER -
BOEHRINGER MICARDIS 3 -
ASTRAZENECA CRESTOR 3 -
EISAI ARICEFT 3 -
MSD EZETROL 3 -
-
-
SUB TOTAL - - 29 -
- SANBE PUMPITOR 5 ESOFERR 1
- SANBE PUMPISEL 5 -
ASTRAZENECA NEXIUM 5 -
DEXA REMOPAIN 6 -
-
-
-
-
-
SUB TOTAL - - 21 1
- MSD ARICEFT 5 FEPEZIL -
- -
-
 -
-
-
-
-
-
SUB TOTAL - - 5 -
- -
- -
-
-
-
-
-
-
-
SUB TOTAL - - - -
TOTAL 74 - 1,133 - 100
Err:520
BE Q1 2022 ACT Q2 BE Q2
2 3 1 2 3 4 5
42 42 34 21 50 43 43
1 1 3 2 2
- -
- -
- -
2 2 2 2
- -
- -
- -
45 45 34 21 53 47 47
- -
1 1 1 1
1 1 1 2
- -
- - 1
- -
- -
- -
- -
2 2 - - - 2 4
1 1 1 1 1 2 3
- -
- -
- -
- -
- -
- -
1 1
- -
2 2 1 1 1 2 3
6 6 1 3 3 4 4
- -
- -
- -
- -
- -
- -
- -
- -
6 6 1 3 3 4 4
1 1 2 2
2 2 2 1 1 2 2
1 1 2 1 4 3 3
2 2 4 1 5 4 4
2 1 3 3 3 2 3
- -
- -
- -
- -
8 7 11 6 13 13 14
3 3 2 1 5 5 5
1 1 3 2 3 2 3
- -
- -
- -
- -
- -
- -
- -
4 4 4 3 7 7 8
1 1 1 1
1 1
- -
- -
- - 1
- -
- -
- -
- -
2 2 - - - 1 2
1 1 2 4 3 2 2
- -
- -
1 1 1 1 1 2
1 1 1 5 1 1
1 1 1 1
- -
- - 2
- -
4 4 4 4 9 5 8
1 1
- -
1 1 1 1 1 1
- -
1 1 1
- -
- -
- -
- -
3 3 1 - 1 1 2
1 1 2 1 1
- -
1 1 3 1 3 2 2
- -
- -
1 1
- -
- -
- -
3 3 3 1 5 3 3
1 2 2 1 1 2 2
1 1 2 1 3 1 1
2 2 3 1 4 3 3
- -
- -
- -
1 1
- -
- -
5 6 7 3 8 6 6
- -
1 1 1 1
- 1
- -
- -
- -
- -
- -
- -
1 2 - - - 1 1
1 1 1 1 2 2
1 1 1 1
- -
- -
1 1
- - 1
- -
- -
- -
3 3 1 - 1 3 4
1 1 1 0 1 2
- -
- -
1 1 1 1 2 2
- -
- -
- -
1 1
- - 1
3 3 1 1 1 3 5
2 2 9 5 2 4 5
- -
- -
- -
- -
- -
- -
- -
- -
2 2 9 5 2 4 5
2 2 1 1 1 1 1
- -
- -
2 2 1 1
- -
- -
- -
- -
- -
4 4 1 1 1 2 2
1 1 1 1 2 2
1 1 1 1
- -
- -
- -
- -
- -
- -
- -
2 2 1 - 1 3 3
- -
- -
1 1 1 2 2
- -
- - 2
- -
- -
- -
- -
1 1 - - 1 2 4
- -
- -
- 1
- -
- -
- -
- -
- -
- -
- 1 - - - - -
2 2
- -
- -
- -
- -
- -
- -
- -
- -
2 2 - - - - -
- 1
- -
- -
 - -
- -
- -
- -
- -
- -
- 1 - - - - -
-
- -
- -
- -
- -
- -
- -
- -
- -
- - - - - - -
102 105 78 47 105 109 125
BE Q2 FERRON AVG FERRON AVG DEADLINE
GR VS 2021 ACTION PLAN
6 Q1 2022 Q2 2022 MONTH
43 35 43 -16.7%
2 1 2 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT MAKANAN TIM APR
2 0 2 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
48 36 47 -14.3%
0 0 #DIV/0!
1 0 1 #DIV/0!
2 0 2 #DIV/0!
0 0 #DIV/0!
ENT BUAH DR NELA,
1 0 1 #DIV/0! MENAWARKAN KOPAPDI APR
SEMARANG BULAN JULI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
4 - 3 #DIV/0!
3 1 3 -33.3%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
IKUT MEMBANTU
0 0 #DIV/0! MENDAFTARKAN WEBINAR APR
ONLINE
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
3 1 3 -33.3%
5 2 4 -60.5%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT STARBUCK JUN
 ENT STARBUCK
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
5 2 4 -60.5%
2 0 2 -100.0%
2 1 2 -33.3%
3 2 3 123.3%
4 3 4 58.3%
3 3 3 #DIV/0! RTD NEURO GROUP MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
14 10 14 63.9%
5 2 5 -17.8%
3 2 3 143.3%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT MAKAN SIANG JUN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
8 5 8 22.5%
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 0 1 #DIV/0! MENAWARKAN KOPAPDI JUL
SEMARANG
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
3 - 2 #DIV/0!
2 3 2 173.3%
0 0 #DIV/0!
0 0 #DIV/0!
2 1 2 -40.0%
1 2 1 100.0% ENT MAKAN SIANG JUN
1 0 1 -100.0%
0 0 #DIV/0!
 ENT MAKAN SIANG

2 0 1 #DIV/0!
0 0 #DIV/0!
8 5 7 33.3%
0 0 -100.0%
0 0 #DIV/0!
1 1 1 33.3%
0 0 #DIV/0!
1 0 1 #DIV/0! PP ONLINE EZEFER MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 1 2 -55.6%
1 1 1 -36.7%
0 0 #DIV/0!
2 2 2 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT MAKAN SIANG MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
3 3 3 #DIV/0!
2 1 2 -33.3%
1 2 1 90.0%
3 3 3 28.3%
0 0 #DIV/0!
0 0 #DIV/0! RTD NEURO GROUP MEI
0 0 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
7 6 6 16.0%
0 0 #DIV/0!
1 0 1 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! RTD NEURO GROUP MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 - 1 #DIV/0!
2 1 2 -46.7%
1 0 1 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 DIIKUT#DIV/0!
SERTAKAN DI ACARA WEBINAR YNG DISUPORT FERRON
JUN
2 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
6 1 4 -46.7%
2 0 2 -25.0%
0 0 #DIV/0!
0 0 #DIV/0!
2 0 2 #DIV/0!
0 0 #DIV/0! WEBINAR KOPAPDI SEMARANG JUN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 0 1 #DIV/0!
6 1 5 66.7%
6 5 5 235.6%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! PMS 5 JT APR
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
6 5 5 235.6%
1 1 1 10.0%
0 0 #DIV/0!
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0! WEBINAR DAN SERBU UGD MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 1 2 10.0%
2 1 2 #DIV/0!

WEBINAR DAN SERBU PRIORITA

1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! WEBINAR DAN SERBU PRIORITA APR
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
3 1 3 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
3 0 2 #DIV/0!
0 0 #DIV/0!
3 0 2 #DIV/0! PMS 5 JT MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
6 0 4 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! WEBINAR JUN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 - 0 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! WEBINAR DAN SERBU UGD JUN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 - 0 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!

STANDARISASI RS OMNI
 0 0 #DIV/0!
0 0 #DIV/0! STANDARISASI RS OMNI MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 - 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 0 0 #DIV/0!
139 77 124 #DIV/0!
PIC (NAMA KETERANGAN
MR/ PIMDA)

WILDAN

WILDAN

WEBINAR ONLINE

WILDAN

WILDAN
WILDAN

WILDAN

WILDAN

WILDAN

WILDAN
WILDAN

WILDAN

WILDAN

WILDAN

WILDAN
WILDAN

WILDAN

WILDAN

WILDAN

WILDAN
WILDAN

WILDAN

WILDAN

WILDAN

WILDAN
WILDAN
 CHANEL RSS
No: 2
Nama Apotik: RS SARI ASIH CIPUTAT

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP?
No
Nama Specialis NORMAL PANDEMI Y/N

1 LINDA KURNIATY W Sp.PD 97 Y

2 PANJI PRIVAN Sp.PD 80 Y

3 LARAS BUDIYANI Sp.PD 72 N

4 POPPY CANDRA DEWI Sp.S 70 Y

4 POPPY CANDRA DEWI Sp.S 70 Y

5 KHRISTI HANDAYANI Sp.S 67 Y

6 BAMBANG DWI P Sp.JP 65 Y

7 MARDLATILLAH Sp.JP 53 N

8 RIESMA VIOVICA SARI Sp.JP 53 N

8 RIESMA VIOVICA SARI Sp.JP 53 N

10 MOCH NAGIEB Lainnya 49 Y

11 AHMAD ZAKI Lainnya 42 N

12 DJAYA PERDANA Sp.B 37 N

13 MOHAMMAD NIZAM ERHAMZA Sp.P 24 Y

 14 ZULIA KHOZANAH ASRORIYAH Lainnya 100 Y

Grand Total 809

Pengguna Feron 8
Bukan Pengguna Ferron 5
 AVERAGE Produk Kompetitor
Product SALES 2021 -Gusur- BE Q1 2022
(AVG JAN – Produk AQ/AO
Existing (FPP) PT. Nama Produk Sales (Rp) 1
OKT 2021)
FONYLIN MR 1 SERVIER DIAMICRON MR 10 FONYLIN MR 2
- DEXA VOMIZOLE 20 -
DEXA STATOR 3 ROSUFER 1
MERCK GLUCOPHAGE X 5 -
SANBE PUMPITOR 10 -
SANBE TEXAGRAM 10 -
EDOTIN 1 DEXA VECTRINE 10 EDOTIN 1
BAYER AVELOX 20 -
-
SUB TOTAL 2 - - 88 - 4
BAYER AVELOX 10 -
- DEXA VOMIZOLE 15 -
DEXA STATOR 6
MERC GLUCOPHAGE X 3 GLUMIN XR 1
SANBE PUMPITOR 20 -
SANBE TEXAGRAM 10 -
DEXA VECTRINE 5 EDOTIN 1
FONYLIN MR 1 SERVIER DIAMICRON MR 10 FONYLIN MR 2
-
SUB TOTAL 1 - - 79 - 4
- BAYER AVELOX 10 -
- DEXA VOMIZOLE 10 -
DEXA ORINOX 6 -
MERC GLUCOPHAGE X 3 -
SANBE PUMPITOR 25 -
DEXA STATOR 8 ROSUFER -
SERVIER DIAMICRON MR 10 FONYLIN MR 2
-
-
SUB TOTAL - - - 72 - 2
- DEXA REMOPAIN 9 -
- PHAPROS TEBOKAN 10 -
KALBE PROVELIN 8 -
ASTRA ZENECA CRESTOR 10 -
PFIZER LYRICA 5 -
 DEXA VOMIZOLE 15 -
DEXA ORINOX 3 -
EISAI ARICEPT 5 -
NEULIN PS 2 KALBE BRAINACT 5 NEULIN PS 3
SUB TOTAL 2 - - 70 - 3
- DEXA REMOPAIN 15 -
- PHAPROS TEBOKAN 3 -
KALBE PROVELIN 5 -
ASTRA ZENECA CRESTOR 4 -
PFIZER LYRICA 5 -
DEXA VOMIZOLE 5 -
NEULIN PS 1 KALBE BRAINACT 5 NEULIN PS 1
SANBE PUMPITOR 10 -
OTHRES 15 -
SUB TOTAL 1 - - 67 - 1
- BOHRINGER MICARDIS 5 -
HYPERIL 1 SANOFI TRITACE 6 HYPERIL 2
NTG 2 DARYA VARIA CEDOCARD 4 NTG 3
DEXA STATOR 5 ROSUFER 2
BOEHRINGER MICARDIS 4 -
ASTRAZENECA CRESTOR 5 -
MSD EZETROL 3 EZEFER 1
CROME -
OTHRES 30 -
SUB TOTAL 3 - - 62 - 8
- BOHRINGER MICARDIS 7 -
- DARYA VARIA CEDOCARD 5 NTG 2
SANOFI TRITACE 4 -
DEXA STATOR 4 ROSUFER -
BOEHRINGER MICARDIS 5 -
ASTRAZENECA CRESTOR 5 -
MSD EZETROL 3 EZEFER -
-
OTHRES 20 -
SUB TOTAL - - 53 2
- BOHRINGER MICARDIS 7 -
- DARYA VARIA CEDOCARD 5 -
SANOFI TRITACE 3 -
DEXA STATOR 4 ROSUFER -
BOEHRINGER MICARDIS 5 -
ASTRAZENECA CRESTOR 6 -
MSD EZETROL 3 EZEFER -
 -
OTHRES 20 -
SUB TOTAL - - 53 -
KETESE 2 DEXA REMOPAIN 17 KETESE 3
- DEXA ORINOX 10 -
PFIZER CELEBREX 5 -
SANBE PUMPITOR 15 -
-
-
-
-
-
SUB TOTAL 2 - - 47 - 3
- DEXA REMOPAIN 17 KETESE -
- DEXA ORINOX 10 -
PFIZER CELEBREX 5 -
SANBE PUMPITOR 10 -
-
-
-
-
-
SUB TOTAL - - - 42 - -
- DEXA REMOPAIN 17 KETESE -
- DEXA ORINOX 10 -
PFIZER CELEBREX 5 -
SANBE PUMPITOR 5 -
-
-
-
-
-
SUB TOTAL - - - 37 - -
- KALBE CRAVIT 5 -
- SANBE SANEXON 5 -
SANBE PUMPITOR 5 -
BAYER AVELOX 5 -
SANBE TEXAGRAM 5 -
RESPITOR 0 RESPITOR 1
-
-
-
SUB TOTAL 0 - - 25 - 1
OMZ 86 - OMZ 83
- - -
-
-
-
-
-
-
-
SUB TOTAL 86 - - - - 83
TOTAL 97 - 658 - 110
TOTAL
27
BE Q1 2022 ACT Q1 BE Q2
2 3 1 2 3 4 5
2 2 2 2 3 4
- -
1 1
- -
- -
- -
1 1
- -
- -
4 4 2 - 2 3 4
- -
- -

1 1 0
- -
- -
1 1
2 2 3 2 3 4
- -
4 4 3 - 2 3 4
- -
- -
- -
- -
- -
- 1
2 2 5 2 5 5 5
- -
- -
2 3 5 2 5 5 5
- -
- -
- -
- -
- -
- -
- -
- -
3 2 1 2
3 2 - - - 1 2
- -
- -
- -
- -
- -
- -
1 1 2 1
- -
- -
1 1 - - - 2 1
- -
1 1 5 1 2
3 2 2 3 1 2
1 1
- -
- -
1 1 1 1
- - 1
- -
6 5 5 3 3 3 5
- -
2 2 3 2 3
- -
1 1 1 1
- -
- -
1 1
- -
- -
4 4 - - 3 3 4
- -
- -
- -
1 1 1
- -
- -
1 1 1
- -
- -
2 2 - - - - 2
3 3 3 4 4 5
- -
- -
- -
- -
- -
- -
- -
- -
3 3 3 - 4 4 5
- 1 1 1
- -
- -
- -
- -
- -
- -
- -
- -
- 1 - - - 1 1
- 1 1
- -
- -
- -
- -
- -
- -
- -
- -
- 1 - - - - 1
- -
- -
- -
- -
- -
1 1 4 2 2 2
- -
- -
- -
 1 1 4 - 2 2 2
81 83 173 251 170 185 185
- -
- -
- -
- -
- -
- -
- -
- -
81 83 173 251 170 185 185
111 112 194 256 191 212 220

30 29
BE Q2 FERRON AVG FERRON AVG DEADLINE
GR VS Q3 ACTION PLAN
6 Q1 2022 Q2 2022 MONTH
5 1 4 40.0%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! MENAWARKAN KOPAPDI SEMARANG JUN
0 0 #DIV/0!
0 0 -100.0%
0 0 #DIV/0!
0 0 #DIV/0!
5 1 4 -6.7%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! MENAWARKAN KOPAPDI SEMARANG JUN
0 0 #DIV/0!
0 0 #DIV/0!
5 2 4 63.3%
0 0 #DIV/0!
5 2 4 66.7%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! MENAWARKAN KOPAPDI SEMARANG JUN
0 0 #DIV/0!
5 4 5 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
5 4 5 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT STARBUCK MEI
 ENT STARBUCK
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
3 0 2 -100.0%
3 - 2 -100.0%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! DIIKUTSERTAKAN PROGRAM PM APR
NEWERA
0 0 #DIV/0!
1 0 1 -100.0%
0 0 #DIV/0!
0 0 #DIV/0!
1 - 1 -100.0%
0 0 #DIV/0!
3 2 2 14.3%
3 2 2 -19.3%
0 0 #DIV/0!
0 0 #DIV/0! RTD EZEFER TGL 21 FEE 2JT APR
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
7 3 5 5.1%
0 0 #DIV/0!
4 1 3 #DIV/0!
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0! PMS 5 JT MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
5 1 4 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0! ENT STARBUCK JAN
0 0 #DIV/0!
1 0 1 #DIV/0!
 ENT STARBUCK

0 0 #DIV/0!
0 0 #DIV/0!
2 - 1 #DIV/0!
6 2 5 -4.2%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT MAKAN SIANG MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
6 2 5 -4.2%
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! WEBINAR ILMIAH JUN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 - 1 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT BUAH JUN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 - 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT BUAH JUN
2 2 2 1966.7%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
 2 2 2 1966.7%
185 198 185 130.2%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! PRESISI MEI
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
185 198 185 130.2%
227 213 220 #DIV/0!
PIC (NAMA KETERANGAN
MR/ PIMDA)

2250
WILDAN

WILDAN

WILDAN

WILDAN
WILDAN

WILDAN

SAHRU

WILDAN

WILDAN
WILDAN

WILDAN

WILDAN

WILDAN

WILDAN
WILDAN
 CHANEL RSS
No: 3
Nama Apotik: 0

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP? Product

No
Existing (FPP)
Nama Specialis NORMAL PANDEMI Y/N

1 BUDI WIJAYA Sp.PD 65 N

SUB TOTAL

2 AMRI HAPSARSp.PD 69 N

SUB TOTAL

3 ANDI NUGROHOSp.PD 60 N

SUB TOTAL

4 THOMAS HENDRISp.S 56 N
4 THOMAS HENDRISp.S 56 N

SUB TOTAL

5 EVELYN JOHNLI Sp.S 57 N

SUB TOTAL
HYPERIL
NTG

6 ANDREAS SOEMSp.JP 51 Y

SUB TOTAL
CEFTUM
KETESE
MEDIXON
OMZ

7 HENDRI ONGKO Sp.B 52 Y

SUB TOTAL
CEFTUM
EDOTIN
HISTRINE
KETRICIN
OMZ
8 LUSIANA MARG Sp.A 46 Y
 8 LUSIANA MARG Sp.A 46 Y

SUB TOTAL

9 RUTH KHARISMSp.A 40 N

SUB TOTAL

10 OTHERS 250 N

SUB TOTAL
Grand Total 681 TOTAL
Pengguna Feron 3 TOTAL 0
Bukan Pengguna Ferron 6
 AVERAGE Produk Kompetitor
SALES 2021 BE Q1
-Gusur- Produk AQ/AO
(AVG JAN –
OKT 2021) PT. Nama Produk Sales (Rp) 1 2
KALBE TORASIC 3 - -
- SANBE SANEXON 3 - -
SANBE PUMPISEL 5 OMZ - 1
DEXA MEDICA RAMIPRIL 4 - -
- -
- -
OTHERS 50 - -
- -
- -
- - - 65 - - 1
- KALBE TORASIC 3 - -
- SANBE SANEXON 3 - -
SANBE PUMPISEL 5 OMZ - -
INTERBAT STARXON 2 - -
DEXA MEDICA RAMIPRIL 6 - -
- -
OTHERS 50 - -
- -
- -
- - - 69 - - -
- KALBE TORASIC 3 - -
- SANBE PUMPISEL 3 OMZ - 1
SANBE SANEXON 2 - -
INTERBAT STARXON 2 - -
DEXA MEDICA RAMIPRIL 5 - -
- -
OTHRES 45 - -
- -
- -
- - - 60 - - 1
- KALBE TORASIC 3 - -
- SANBE SANEXON 3 - -
SANBE PUMPISEL 3 OMZ - -
INTERBAT STARXON 4 - -
 DEXA MEDICA RAMIPRIL 3 - -
- -
OTHRES 40 - -
- -
- -
- - - 56 - - -
- KALBE TORASIC 3 - -
- SANBE SANEXON 3 - -
SANBE PUMPISEL 5 OMZ - -
INTERBAT STARXON 2 - -
DEXA MEDICA RAMIPRIL 4 - -
- -
OTHRES 40 - -
- -
- -
- - - 57 - - -
1 DEXA MEDICA RAMIPRIL 6 HYPERIL 1 1
0 DARYA VARIA CEDOCARD 5 NTG 1 1
- -
- -
- -
OTHRES 40 - -
- -
- -
- -
1 - - 51 - 2 2
1 KALBE BROADCED 5 CEFTUM 1 1
3 KALBE TORASIC 3 KETESE 3 3
LAPI LAMESON 1 MEDIXON - -
1 KALBE PRANZA 3 OMZ 1 1
- -
- -
OTHRES 40 - -
- -
- -
5 - 52 5 5
0 INTERBAT STARXON 2 CEFTUM 1 1
1 KALBE VESTEIN 5 EDOTIN 1 1
1 INTERBAT INTRIZIN 6 HISTRINE 1 1
2 SANBE CERINI 11 KETRICIN 2 2
DEXA MEDICA GASTROFER 2 OMZ 1 1
- -
 - -
OTHRES 20 - -
- -
3 - 46 6 6
- INTERBAT TRIAMCORT 9 KETRICIN - -
- TAISHO KENACORT 4 - -
DEXA MEDICA VECTRINE 7 - -
- -
- -
OTHRES 20 - -
- -
- -
- -
- - 40 - -
- - -
- - -
- -
- -
- -
- -
- -
- -
- -
- - - - -
9 496 13 15
BE Q1 ACT Q1 BE Q2

3 1 2 3
-
-
1 1 1
-
-
-
-
-
-
1 - - - - 1 1
-
-
1 1 1
-
-
-
-
-
-
1 - - - - 1 1
-
1 1
-
-
-
-
-
-
-
1 - - - - - 1
-
-
1 1 1
-
-
-
-
-
-
1 - - - - 1 1
-
-
1 1 1
-
-
-
-
-
-
1 - - - - 1 1
1 1 1 1
1 1 1
-
-
-
-
-
-
-
2 - - - 1 2 2
1 1 1 2 3
3 5 5 4 5 6 7
-
1 1 1 1 1
-
-
-
-
-
5 7 5 4 7 9 11
1 3 3 2 3 4
1 2 2 1 2 2 2
1
2 1 2 3 3
1 1 1 1
-
 -
-
-
6 6 2 4 7 9 10
1 1 1 1
-
-
-
-
-
-
-
-
1 - - - 1 1 1
-
-
-
-
-
-
-
-
-
- - - - - - -
18 13 7 8 16 25 29
FERRON AVG FERRON AVG GR VS Q3 ACTION PLAN DEADLINE PIC (NAMA KETERANGAN
Q1 2022 Q2 2022 MONTH MR/ PIMDA)

0 0 #DIV/0!
0 0 #DIV/0!
0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT MINUMAN JUN WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT MAKANAN JUN WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT MAKANAN JUN WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 1 #DIV/0!
0 0 #DIV/0!
ENT BUAH WILDAN
0 0 #DIV/0! ENT BUAH MAR WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! WEBINAR MAR WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 1 #DIV/0!
0 1 -100.0%
0 1 -100.0%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! RTD NTG JUN WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 2 -100.0%
0 2 -33.3%
5 6 43.4%
0 0 #DIV/0!
0 1 -61.1%
0 0 #DIV/0! PMS 5 JT APR WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
5 9 19.3%
2 3 400.0%
1 2 40.0%
0 0 -100.0%
0 3 -77.8%
0 1 #DIV/0! ENT BUAH MEI WILDAN
0 0 #DIV/0!
 ENT BUAH WILDAN

0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
4 9 9.8%
0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT BUAH MAR WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
- - #DIV/0!
9 23 4.6%
 CHANEL RSS
No: 3
Nama Apotik: RS EMC TANGERANG

DATA DALAM PER SEJUTA ( / 1.000.000)

Dokter Potensi Pengguna FPP?
No
Nama Specialis NORMAL PANDEMI Y/N

1 MUTHOLIP ABDULLAH Sp.PD 57 Y

2 SUHARNOWO Sp.PD 38 N

3 GUSTAN SYAHRI AM Sp.PD 31 N

4 MIRNA NURASTRI Sp.PD 31 Y

4 MIRNA NURASTRI Sp.PD 31 Y

5 HARTONO PRABOWO Sp.S 30 Y

6 ABDUL CHALIM MUTANSIR Sp.S 28 N

7 AS HARIADI Sp.S 19 N

8 EDDY SOENARTO Sp.S 16 Y

 8 EDDY SOENARTO Sp.S 16 Y

9 ARON HUSINK Sp.JP 50 N

10 HERENDA MEDISHITA PRASTYA Sp.JP N

30
Grand Total 330
Pengguna Feron 4
Bukan Pengguna Ferron 6
 AVERAGE Produk Kompetitor
Product SALES 2021 -Gusur- BE Q1
(AVG JAN – Produk AQ/AO
Existing (FPP) PT. Nama Produk Sales (Rp) 1
OKT 2021)
ROSUFER 1 ASTRA CRESTOR 3 ROSUFER 2
- MSD EZETROL 2 EZEFER 2

-
-
OTHERS 40 -
-
SUB TOTAL 1 - - 45 - 4
ASTRA NEXIUM 5 ESOFERR 2
- LAPI LAMESON 2 MEDIXON 1
LAPI TOFEDEX 3 -
ASTRA CRESTOR 3 -
MERCK GLUCOPHAGE 5 -
-
-
OTHERS 20 -
-
SUB TOTAL - - - 38 - 3
- DEXA INBUMIN 3 -
- SERVIER DIAMICRONE 3 -
ASTRA NEXIUM 5 ESOFERR -
-
-
OTHRES 20 -
-
-
-
SUB TOTAL - - - 31 - -
- ASTRA NEXIUM 4 ESOFERR 2
- SEVIER DIAMICRONE 2
ASTRA CRESTOR 3 ROSUFER 1
ROSUFER 2
 -
OTHRES 20 -
-
SUB TOTAL 2 - - 29 - 3
- KALBE BRAINACT 2 NEULIN PS 1
MEDIXON 1 PFIZER MEDROL 5 MEDIXON 2
ASTRA NEXIUM 5 ESOFERR 1

-
OTHERS 15 -
-
-
SUB TOTAL 1 - - 27 - 4
- KALBE BRAINACT 2 NEULIN PS -
- KALBE BRAINACT 1 -
PFIZER LYRICA 5 PGB -
-
-
OTHRES 20 -
-
-
-
SUB TOTAL - - - 28 - -
- KALBE BRAINACT 4 NEULIN PS 1
- PFIZER LYRICA 5 PGB 1
ESOFERR -
BIOBRAN -
OTHRES 10 -
-
-
-
-
SUB TOTAL - - - 19 - 2
NEULIN PS 0 KALBE BRAINACT 2 NEULIN PS 1
- KALBE BRAINACT 3 -
PFIZER LYRICA 4 PGB 2
ROSUFER 1 DEXA STATOR 3 ROSUFER 1
ASTRA NEXIUM 4 ESOFERR 1
-
-
 -
-
SUB TOTAL 1 - - 16 - 5
- DEXA STATOR 5 ROSUFER 1
- - HYPERIL -
NTG -
-
-
-
-
-
-
SUB TOTAL - - 5 - 1
- DEXA STATOR 6 ROSUFER -
- - HYPERIL -
NTG -
-
-
-
-
-
-
SUB TOTAL - - 6 -
TOTAL 5 244 22
TOTAL RS EMC TANGERANG
BE Q1 ACT Q1 BE Q2
2 3 1 2 3 4 5
2 2 1 1 0 1 1
2 2 0 1 1

- -
- -
- -
- -
4 4 1 1 1 2 2
2 2
1 1 1 2
- -
- -
- -
- -
- -
- -
- -
3 3 1 - - - 2
- -
- -
- 2
- -
- -
- -
- -
- -
- -
- 2 - - - - -
2 2 -

1 1 -
- -
- -
- -
3 3 - - - - -
1 1
2 2 1 1 3 1 1
2 1

- -
- -
- -
- -
5 4 1 1 3 1 1
- 1
- -
- 1
- -
- -
- -
- -
- -
- -
- 2 - - - - -
1 1
1 1
- - 1 1 2
- -
- -
- -
- -
- -
- -
2 2 - - 1 1 2
1 1 1 2
- -
2 1 1 2
1 1
1 1
- -
- -
 - -
- -
5 4 - - - 2 4
1 1
- - 1 1 1 1 1
- - 1 1 1
- -
- -
- -
- -
- -
- -
1 1 2 1 1 2 2
- -
- - 1 2
- - 1 1
- -
- -
- -
- -
- -
- -
- - - - - 2 3
23 25 4 3 6 10 16
BE Q2 FERRON AVG FERRON AVG DEADLINE PIC (NAMA
GR VS Q3 ACTION PLAN
6 Q1 2022 Q2 2022 MONTH MR/ PIMDA)
1 1 1 -30.0%
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
ENTERTAIN COFFE (STARBUCKS)
APR WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 1 2 -20.0%
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!ENT COFFE/COKLAT MEI WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
KERJASAMA DEAL ESOFER MEI WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 - 0 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
1 0 0 #DIV/0!
0 0 -100.0%
0 0 #DIV/0!ENT COFFE/COKLAT APR WILDAN
 ENT COFFE/COKLAT WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 - 1 -100.0%
0 0 #DIV/0!
1 2 1 50.0%
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT BUAH MEI WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 2 1 50.0%
0 0 #DIV/0!
0 0 #DIV/0!
1 0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
DEAL KERJASAMA NEULIN PSMEI WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 - 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT BUAH MEI WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
1 0 1 #DIV/0!
1 0 1 -100.0%
0 0 #DIV/0!
1 0 1 #DIV/0!
0 0 -100.0%
0 0 #DIV/0! ENT MAKANAN JUN WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
 ENT MAKANAN WILDAN

0 0 #DIV/0!
0 0 #DIV/0!
2 - 3 -100.0%
0 0 #DIV/0!
1 1 1 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 ENT MAKANAN DAN SOP DUREN
#DIV/0! MEI WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
2 1 2 #DIV/0!
0 0 #DIV/0!
3 0 2 #DIV/0!
1 0 1 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0! ENT BUAH APR WILDAN
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
0 0 #DIV/0!
4 - 3 #DIV/0!
17 4 14 -15.4%
KETERANGAN
DATA DALAM PER SEJUTA ( / 1.000.000)

JUMLAH
BRANCH DESC SUP ASM NAME NO NAMA MR SPESIALIS POPULASI
DIA AREA
MRNYA

TGR SAHRU RAMADHAN 1 WILDAN ANTON N NEUROLOGI 18

TGR SAHRU RAMADHAN 2 WILDAN ANTON N INTERNIST 36
TGR SAHRU RAMADHAN 3 WILDAN ANTON N CARDIO 17
TGR SAHRU RAMADHAN 4 WILDAN ANTON N BEDAH UMUM 11
TGR SAHRU RAMADHAN 5 WILDAN ANTON N BEDAH SYARAF 6
TGR SAHRU RAMADHAN 6 WILDAN ANTON N BEDAH ORTHOPAEDI 7
TGR SAHRU RAMADHAN 7 WILDAN ANTON N BEDAH DIGESTIF 5
TGR SAHRU RAMADHAN 8 WILDAN ANTON N ANASTHESI 12
TGR SAHRU RAMADHAN 9 WILDAN ANTON N OBGYN 27
TGR SAHRU RAMADHAN 10 WILDAN ANTON N ANAK 25
TGR SAHRU RAMADHAN 11 WILDAN ANTON N PARU 11
TGR SAHRU RAMADHAN 12 WILDAN ANTON N THT 15
TGR SAHRU RAMADHAN 13 WILDAN ANTON N GP/UGD 27
TGR SAHRU RAMADHAN 14 WILDAN ANTON N OTHERS 1
218

NOTE :
1, SLS DLM JUTAAN
2.POTENSI SALES DIDAPAT DARI DATA SURVEY UTK ALL KOMPETITOR PRDUK FPP & PROD
3. SEMUA POPULASI SPESIALIS ( CARDIO, NEURO,INTERNIST)--->WAJIB MASUK MCL
4. TDK MERUBAH KOLOM & URUTAN SPESIALIS
5. RK PENAMBAHAN USER SELAMA Q1 2022, NAMANYA HARUS MUNCUL KE DALAM RK Q
 2021 KUM Q1 2022

POTENSI JUMLAH MCL JUMLAH USER SALES AVG SLS/USER MCL USER

300 8 6 27 5 8 8
821 13 13 35 3 16 16
184 10 10 29 3 10 7
150 3 4 65 16 4 2
36 1 1 10 10 1 1
230 4 4 20 5 4 2
200 1 0 0 0 0 0
100 0 0 0 0 0 0
200 0 0 0 0 0 0
336 8 8 25 3 8 3
76 3 2 2 1 3 3
25 0 0 0 0 0 0
150 2 2 5 3 4 4
100 1 1 83 83 2 1
2908 54 51 301 131 60 47

MPETITOR PRDUK FPP & PRODUK FPP

)--->WAJIB MASUK MCL

RUS MUNCUL KE DALAM RK Q1

UM Q1 2022 KUM Q2 2021 KUM Q3 2021

SALES(JT) MCL USER SALES(JT) MCL USER SALES(JT)

22 14 11 40
36 19 18 63
23 11 8 24
58 3 3 58
4 1 1 7
13 3 3 18
0 0 0 0
0 0 0 0
0 0 0 0
10 2 2 12
2 0 0 0
0 0 0 0
13 4 3 18
86 1 1 185
267 58 50 425
 OKT NOV DES

MCL USER SALES(JT) MCL USER SALES(JT) MCL

DES

USER SALES(JT)
PRODUCT GROUP

AGGRAVAN
ARCERIN
B-BETA
BIOBRAN
BNERVO
CEFTUM
CLOTIX
COXIRON
CROME
DEGRADE
DEGRIUM
DORBAZ
EDOTIN
ESOFERR
ESOFERR CAP
EXEPIME
EZEFER
FEPEZIL
FERBULIN
FONYLIN MR
FUNGATIN
GANIN
GLUBOSE
GLUMIN XR
GLUMIN_TAB
GRAVOMIT
HISTRINE
HYPERIL
KETESE
KETRICIN
MAGALAT
MECOX
MEDIXON
MOLCIN
MORCEF
NEULIN
NEULIN PS
NICAFER
NTG
OMZ
PERMYO
PGB
POSAFIT
QUIDEX
RESPITOR
ROSUFER
TELSAT
TRIXIM
OTHERS